Tiaa, Fsb Halozyme Therapeutics, Inc. Transaction History

Tiaa, Fsb

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$38.84 - $51.31 $941,675 - $1.24 Million	-24,245 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$39.51 - $51.45 $1,777 - $2,315	45 Added 0.19%	24,245 $1.01 Million
Q4 2020 Jan 21, 2021	SELL	$25.81 - $43.62 $122,184 - $206,497	-4,734 Reduced 16.36%	24,200 $1.03 Million
Q3 2020 Oct 13, 2020	SELL	$25.74 - $29.63 $9,601 - $11,051	-373 Reduced 1.27%	28,934 $760,000
Q2 2020 Jul 15, 2020	SELL	$16.25 - $26.81 $130,000 - $214,480	-8,000 Reduced 21.44%	29,307 $786,000
Q1 2020 Apr 21, 2020	SELL	$13.9 - $21.83 $225,027 - $353,405	-16,189 Reduced 30.26%	37,307 $671,000
Q4 2019 Jan 13, 2020	BUY	$14.93 - $19.53 $49,149 - $64,292	3,292 Added 6.56%	53,496 $948,000
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $57,230 - $66,968	-3,880 Reduced 7.17%	50,204 $863,000
Q1 2019 Apr 15, 2019	SELL	$13.94 - $17.58 $82,469 - $104,003	-5,916 Reduced 9.86%	54,084 $871,000
Q4 2018 Apr 15, 2019	BUY	$13.33 - $18.66 $799,800 - $1.12 Million	60,000 New	60,000 $878,000
Q4 2018 Feb 22, 2019	SELL	$13.33 - $18.66 $813,130 - $1.14 Million	-61,000 Closed	0 $0
Q3 2018 Oct 18, 2018	SELL	$16.68 - $18.41 $58,380 - $64,435	-3,500 Reduced 5.43%	61,000 $1.11 Million
Q2 2018 Jul 20, 2018	SELL	$16.87 - $20.3 $168,700 - $203,000	-10,000 Reduced 13.42%	64,500 $1.09 Million
Q1 2018 Apr 18, 2018	BUY	$17.06 - $21.2 $1.27 Million - $1.58 Million	74,500 New	74,500 $1.46 Million

541

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.63B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

Stay updated on Tiaa, Fsb with notifications on news.